These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22157563)

  • 21. ACE inhibition in hypertension: focus on perindopril.
    Cockcroft JR
    Am J Cardiovasc Drugs; 2007; 7(5):303-17. PubMed ID: 17953470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM
    Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C; Croce G; Desideri G
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 3, 2-Drug Combinations of Antihypertensive Therapies on Blood Pressure Variability in Black African Patients: Secondary Analyses of the CREOLE Trial.
    Ojji DB; Cornelius V; Partington G; Francis V; Pandie S; Smythe W; Hickman N; Barasa F; Damasceno A; Dzudie A; Jones E; Ingabire PM; Mondo C; Ogah O; Ogola E; Sani MU; Shedul GL; Shedul G; Rayner B; Sliwa K; Poulter N;
    Hypertension; 2022 Nov; 79(11):2593-2600. PubMed ID: 36052684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial.
    Gupta AK; Poulter NR; Dobson J; Eldridge S; Cappuccio FP; Caulfield M; Collier D; Cruickshank JK; Sever PS; Feder G;
    Am J Hypertens; 2010 Sep; 23(9):1023-30. PubMed ID: 20725056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twenty-four-hour ambulatory blood pressure reduction with a perindopril/amlodipine fixed-dose combination.
    Nagy VL
    Clin Drug Investig; 2013 Jul; 33(7):469-76. PubMed ID: 23681954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention of cardiovascular events by the antihypertensive treatment using amlodipine and perindopril in comparison with the use of atenolol and bendroflumethiazide. The ASCOT (Anglo-Scandinavian Outcomes Trail: blood pressure lowering arm) study results--multicentre, randomised, controlled trial. Landmark in the development of opinions on combination therapy in hypertension? (comment)].
    Widimský J
    Vnitr Lek; 2005 Dec; 51(12):1394-6, 1398-9. PubMed ID: 16430107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The best of hypertension 2005].
    Chamontin B
    Arch Mal Coeur Vaiss; 2006 Jan; 99 Spec No 1(1):35-41. PubMed ID: 16479962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers].
    van den Meiracker AH; van Montfrans GA
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):886-8. PubMed ID: 16686086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASCOT blood pressure-lowering arm--study of effects of two BP-lowering regimens in hypertensive patients with cardiovascular risk factors.
    Cardiovasc J S Afr; 2005; 16(2):124, 126-7. PubMed ID: 15915281
    [No Abstract]   [Full Text] [Related]  

  • 33. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M
    J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
    Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for improvement in survival with antihypertensive combination treatment.
    Ruschitzka F
    J Hypertens; 2011 Dec; 29 Suppl 1():S9-14. PubMed ID: 22157566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.
    Jamerson KA; Bakris GL; Wun CC; Dahlöf B; Lefkowitz M; Manfreda S; Pitt B; Velazquez EJ; Weber MA
    Am J Hypertens; 2004 Sep; 17(9):793-801. PubMed ID: 15363822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [ASCOT Study of optimal hypertension therapy. New study results against the "diuretics first" recommendation].
    MMW Fortschr Med; 2005 Dec; 147(49-50):66-7. PubMed ID: 16402454
    [No Abstract]   [Full Text] [Related]  

  • 39. The VALUE trial: a commentary.
    Sever P
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):99-101. PubMed ID: 15526243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.